Low dose interleukin-2 selectively expands circulating regulatory T cells but fails to promote liver allograft tolerance in humans. (2023)
Attributed to:
USE OF LOW-DOSE IL-2 TO EXPAND ENDOGENOUS REGULATORY T CELLS AND ACHIEVE TRANSPLANTATION TOLERANCE
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.jhep.2022.08.035
PubMed Identifier: 36087863
Publication URI: http://europepmc.org/abstract/MED/36087863
Type: Journal Article/Review
Volume: 78
Parent Publication: Journal of hepatology
Issue: 1
ISSN: 0168-8278